HOME › DRUGS › LEPIRUDIN
ACTIVE SUBSTANCE / INN

LEPIRUDIN

Brand name(s): Refludan
EMA LISTED
WITHDRAWN
Thromboembolism;Thrombocytopenia
ACTIVE SUBSTANCE
Lepirudin
REGULATORS
EMA
SPONSORS / MAH
Celgene Europe Ltd.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RefludanCelgene Europe Ltd.Withdrawn13/03/1997Thromboembolism;Thrombocytopenia

FULL INTELLIGENCE ON LEPIRUDIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →